Status:
COMPLETED
Immune Responses to Pneumococcal Vaccination Among HIV-infected Subjects
Lead Sponsor:
US Department of Veterans Affairs
Collaborating Sponsors:
Albert Einstein College of Medicine
Montefiore Medical Center
Conditions:
HIV Infections
Eligibility:
All Genders
18+ years
Phase:
NA
Brief Summary
The purpose of this study is to evaluate the best timing for administering pneumococcal vaccine (PV) to HIV-infected adults that have CD4 cell counts of more than 200 and are not yet receiving combina...
Eligibility Criteria
Inclusion
- HIV infected
- CD4 count \>200
- no acute illness
- no pneumococcal vaccination within 3 years
- naive to treatment or if previously on treatment, no antiretroviral treatment for at least 6 months
- willingness to start antiretroviral treatment as recommended by current guidelines
Exclusion
- prior pneumococcal vaccination within 3 years
- prior AIDS diagnosis based on opportunistic disease
- acute illness
Key Trial Info
Start Date :
October 1 2008
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
September 1 2012
Estimated Enrollment :
107 Patients enrolled
Trial Details
Trial ID
NCT00706550
Start Date
October 1 2008
End Date
September 1 2012
Last Update
April 24 2014
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Michael E DeBakey VA Medical Center
Houston, Texas, United States, 77030